104th German X-ray Congress
Visit us at booth Süd 36 at the 104th German X-ray Congress (RÖKO2023) to learn more about our complete solution for the early detection, diagnosis, and management of neurological disorders.
Advanced MRI
Attending Advanced MRI? Stop by booth 4 to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.
ASNR 2023
Attending ASNR 2023? Stop by booth 603 to learn about our complete solution for the early detection, diagnosis, and management of neurological disorders.
Optimizing cCOG, a Web‐based tool, to detect dementia with Lewy bodies
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring A.M. van Gils, M. van de Beek,…
Development and design of a diagnostic report to support communication in dementia: Co-creation with patients and care partners
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring A.M. van Gils, L.N.C. Visser, H.M.A. Hendriksen,…
Combinostics Selected to Progress to the Finals of neurotechprize
Combinostics has been selected by the jury to progress to the finals for the neurotechprize run by EIT Health and Biogen. The award recognizes technological innovations for the diagnosis and care of Alzheimer’s patients.
![Read more about the article Decreased gray—white matter contrast of [11C]-PiB uptake in cognitively unimpaired subjects with severe obstructive sleep apnea](https://www.combinostics.com/wp-content/uploads/2022/02/Publications_JPAD_500x300.jpg)
Decreased gray—white matter contrast of [11C]-PiB uptake in cognitively unimpaired subjects with severe obstructive sleep apnea
The Journal of Prevention of Alzheimer's Disease S. Ylä-Herttuala, M. Hakulinen, P. Poutiainen, J. Lötjönen,…
Using innovation and AI to redefine radiology: 5 takeaways from RSNA 2021
The theme of RSNA 2021 was “Redefining Radiology,” and, according to our CEO Richard Hausmann, the event delivered. Read Richard's 5 takeaways, from the potential of AI for radiology to the importance of data for patient care.
Combinostics Demonstrates Latest cNeuro® Features and Applications at RSNA 2021
Combinostics will demonstrate the features of cNeuro® 2.0, the latest release to their AI-based suite of products, and applications under development at RSNA 2021.
Arterys Partners with Combinostics to Accelerate Accurate and Consistent Evaluations of Patients with Neurodegenerative Disease and Multiple Sclerosis
Arterys has partnered with Combinostics to offer the most comprehensive neuro AI suite on the market, covering a broad set of applications in neuroradiology .
